{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:24:02Z","timestamp":1793316242640,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["E27234"],"award-info":[{"award-number":["E27234"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parkinson's UK","award":["G-2103"],"award-info":[{"award-number":["G-2103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Heterozygous mutations in the glucocerebrosidase gene (\n                      <jats:italic>GBA1<\/jats:italic>\n                      ), which encodes the lysosomal enzyme \u03b2-glucocerebrosidase (GCase), are a genetic risk factor for Parkinson\u2019s disease (PD). The pathophysiological consequences of\n                      <jats:italic>GBA1<\/jats:italic>\n                      mutations on dopaminergic neuronal function, especially their impact on lysosomal function, mitophagy, and mitochondrial bioenergetics, remain unclear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fibroblasts and dopaminergic neurons generated from induced pluripotent stem cells (iPSCs) derived from patients with\u00a0GBA1-PD were used in the study. Live-cell imaging was performed to measure lysosomal acidification, protease activity, mitochondrial membrane potential, and mitophagy. Mitochondrial morphology and autophagic vesicles were examined using transmission electron microscopy. Oxygen consumption rate was measured by Seahorse assay. V-ATPase assembly was quantified using fluorescence lifetime imaging with F\u00f6rster resonance energy transfer (FLIM-FRET), and pharmacological interventions included rapamycin and acidic nanoparticles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      GCase activity, lysosomal acidification, protease activity, mitophagy and mitochondrial bioenergetic function were all impaired in\n                      <jats:italic>GBA1<\/jats:italic>\n                      mutant dopaminergic neurons. Mitochondria were fragmented, with reduced membrane potential and oxygen consumption. Mechanistic target of rapamycin complex 1 (MTORC1) was constitutively phosphorylated and FLIM-FRET measurements confirmed impairment of lysosomal V-ATPase assembly, which was reversed by rapamycin treatment. Rapamycin and lysosome-targeting acidic nanoparticles rescued lysosomal pH and restored mitophagy, mitochondrial membrane potential and mitochondrial oxidative phosphorylation complex level in the\n                      <jats:italic>GBA1<\/jats:italic>\n                      mutant dopaminergic neurons.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We revealed a novel mechanistic link between\n                      <jats:italic>GBA1<\/jats:italic>\n                      mutations and mitochondrial dysfunction, as the disruption of V-ATPase assembly driven by MTORC1 activation impairs lysosomal acidification. This causes impairment of mitophagy, leading to mitochondrial dysfunction, undermining dopaminergic cell function and fate. Pharmacological intervention with rapamycin or acidic nanoparticles restores lysosomal pH and rescue mitochondrial function, representing a novel therapeutic approach for\u00a0GBA1-PD .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40035-026-00559-z","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:01:21Z","timestamp":1781704881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting lysosomal pH restores mitochondrial quality control in GBA1-mutant Parkinson\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3255-5644","authenticated-orcid":false,"given":"Preethi","family":"Sheshadri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alicia","family":"Costa-Besada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Kiraly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritarth","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Kourouzidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Blacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orian S.","family":"Shirihai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Grinstaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Duchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"559_CR1","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med. 2009;361:1651\u201361.","journal-title":"N Engl J Med"},{"key":"559_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105842","volume":"23","author":"ML Furderer","year":"2022","unstructured":"Furderer ML, Hertz E, Lopez GJ, Sidransky E. Neuropathological features of Gaucher disease and Gaucher disease with parkinsonism. Int J Mol Sci. 2022;23:5842.","journal-title":"Int J Mol Sci"},{"key":"559_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","volume":"81","author":"A Lwin","year":"2004","unstructured":"Lwin A. Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab. 2004;81:70\u20133.","journal-title":"Mol Genet Metab"},{"key":"559_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/mds.25248","volume":"28","author":"R Duran","year":"2013","unstructured":"Duran R, Mencacci NE, Angeli AV, Shoai M, Deas E, Houlden H, et al. The glucocerobrosidase E326K variant predisposes to Parkinson\u2019s disease, but does not cause Gaucher\u2019s disease. Mov Disord. 2013;28:232\u20136.","journal-title":"Mov Disord"},{"key":"559_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00676-7","volume":"18","author":"MT Henrich","year":"2023","unstructured":"Henrich MT, Oertel WH, Surmeier DJ, Geibl FF. Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential. Mol Neurodegener. 2023;18:83.","journal-title":"Mol Neurodegener"},{"key":"559_CR6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cmet.2013.04.014","volume":"17","author":"LD Osellame","year":"2013","unstructured":"Osellame LD, Rahim AA, Hargreaves IP, Gegg ME, Richard-Londt A, Brandner S, et al. Mitochondria and quality control defects in a mouse model of Gaucher disease\u2014links to Parkinson\u2019s disease. Cell Metab. 2013;17:941\u201353.","journal-title":"Cell Metab"},{"key":"559_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41556-018-0244-7","volume":"21","author":"RE Lawrence","year":"2019","unstructured":"Lawrence RE, Zoncu R. The lysosome as a cellular centre for signalling, metabolism and quality control. Nat Cell Biol. 2019;21:133\u201342.","journal-title":"Nat Cell Biol"},{"key":"559_CR8","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1080\/15548627.2020.1771858","volume":"17","author":"AH Ponsford","year":"2021","unstructured":"Ponsford AH, Ryan TA, Raimondi A, Cocucci E, Wycislo SA, Fr\u00f6hlich F, et al. Live imaging of intra-lysosome pH in cell lines and primary neuronal culture using a novel genetically encoded biosensor. Autophagy. 2021;17:1500\u201318.","journal-title":"Autophagy"},{"key":"559_CR9","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1084\/jem.20170453","volume":"214","author":"MA Rujano","year":"2017","unstructured":"Rujano MA, Cannata Serio M, Panasyuk G, P\u00e9anne R, Reunert J, Rymen D, et al. Mutations in the X-linked ATP6AP2 cause a glycosylation disorder with autophagic defects. J Exp Med. 2017;214:3707\u201329.","journal-title":"J Exp Med"},{"key":"559_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/15548627.2018.1509818","volume":"15","author":"H Li","year":"2019","unstructured":"Li H, Ham A, Ma TC, Kuo S-H, Kanter E, Kim D, et al. Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations. Autophagy. 2019;15:113\u201330.","journal-title":"Autophagy"},{"key":"559_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/mds.25462","volume":"28","author":"B Dehay","year":"2013","unstructured":"Dehay B, Martinez\u2010Vicente M, Caldwell GA, Caldwell KA, Yue Z, Cookson MR, et al. Lysosomal impairment in Parkinson\u2019s disease. Mov Disord. 2013;28:725\u201332.","journal-title":"Mov Disord"},{"key":"559_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171441","volume":"13","author":"A Falace","year":"2024","unstructured":"Falace A, Volpedo G, Scala M, Zara F, Striano P, Fassio A. V-ATPase dysfunction in the brain: genetic insights and therapeutic opportunities. Cells. 2024;13:1441.","journal-title":"Cells"},{"key":"559_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neuron.2020.12.015","volume":"109","author":"CN Byrns","year":"2021","unstructured":"Byrns CN, Bonini NM. An integrated multi-omics approach identifies therapeutic potential for ATP6V1A in late onset Alzheimer\u2019s disease. Neuron. 2021;109:193\u20134.","journal-title":"Neuron"},{"key":"559_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2020.11.002","volume":"109","author":"M Wang","year":"2021","unstructured":"Wang M, Li A, Sekiya M, Beckmann ND, Quan X, Schrode N, et al. Transformative network modeling of multi-omics data reveals detailed circuits, key regulators, and potential therapeutics for Alzheimer\u2019s disease. Neuron. 2021;109:257-272.e14.","journal-title":"Neuron"},{"key":"559_CR15","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/brain\/awy092","volume":"141","author":"A Fassio","year":"2018","unstructured":"Fassio A, Esposito A, Kato M, Saitsu H, Mei D, Marini C, et al. De novo mutations of the ATP6V1A gene cause developmental encephalopathy with epilepsy. Brain. 2018;141:1703\u201318.","journal-title":"Brain"},{"key":"559_CR16","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1093\/brain\/awac145","volume":"145","author":"R Guerrini","year":"2022","unstructured":"Guerrini R, Mei D, Kerti-Szigeti K, Pepe S, Koenig MK, Von Allmen G, et al. Phenotypic and genetic spectrum of ATP6V1A encephalopathy: a disorder of lysosomal homeostasis. Brain. 2022;145:2687\u2013703.","journal-title":"Brain"},{"key":"559_CR17","doi-asserted-by":"publisher","first-page":"eadg1925","DOI":"10.1126\/sciadv.adg1925","volume":"9","author":"E Im","year":"2023","unstructured":"Im E, Jiang Y, Stavrides PH, Darji S, Erdjument-Bromage H, Neubert TA, et al. Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr682 -phosphorylated APP \u03b2CTF. Sci Adv. 2023;9:eadg1925.","journal-title":"Sci Adv."},{"key":"559_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5028","volume":"5","author":"DC Sch\u00f6ndorf","year":"2014","unstructured":"Sch\u00f6ndorf DC, Aureli M, McAllister FE, Hindley CJ, Mayer F, Schmid B, et al. iPSC-derived neurons from GBA1-associated Parkinson\u2019s disease patients show autophagic defects and impaired calcium homeostasis. Nat Commun. 2014;5:4028.","journal-title":"Nat Commun"},{"key":"559_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3565","volume":"14","author":"C Settembre","year":"2013","unstructured":"Settembre C, Fraldi A, Medina DL, Ballabio A. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol. 2013;14:283\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"559_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00397-6","volume":"8","author":"A Navarro-Romero","year":"2022","unstructured":"Navarro-Romero A, Fernandez-Gonzalez I, Riera J, Montpeyo M, Albert-Bayo M, Lopez-Royo T, et al. Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology. npj Park Dis. 2022;8:126.","journal-title":"npj Park Dis"},{"key":"559_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41531-022-00423-7","volume":"8","author":"GS Virdi","year":"2022","unstructured":"Virdi GS, Choi ML, Evans JR, Yao Z, Athauda D, Strohbuecker S, et al. Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson\u2019s disease in midbrain dopaminergic neurons. NPJ Parkinsons Dis. 2022;8:162.","journal-title":"NPJ Parkinsons Dis"},{"key":"559_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38165-6","volume":"14","author":"J Zeng","year":"2023","unstructured":"Zeng J, Acin-Perez R, Assali EA, Martin A, Brownstein AJ, Petcherski A, et al. Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease. Nat Commun. 2023;14:2573.","journal-title":"Nat Commun"},{"key":"559_CR23","doi-asserted-by":"crossref","unstructured":"Merrill RA, Flippo KH, Strack S. Measuring Mitochondrial Shape with ImageJ. In: Strack S, Usachev YM, editors. Techniques to investigate mitochondrial function in neurons [Internet]. New York, NY: Springer; 2017 [cited 2025 Apr 10]. p. 31\u201348.","DOI":"10.1007\/978-1-4939-6890-9_2"},{"issue":"4","key":"559_CR24","doi-asserted-by":"crossref","DOI":"10.4081\/ejh.2015.2576","volume":"58","author":"AC Croce","year":"2014","unstructured":"Croce AC, Bottiroli G. Autofluorescence spectroscopy and imaging: a tool for biomedical research and diagnosis. Eur J Histochem. 2014;58(4):2461.","journal-title":"Eur J Histochem"},{"key":"559_CR25","doi-asserted-by":"crossref","unstructured":"Chung C-Y, Singh K, Sheshadri P, Valdebenito GE, Chacko AR, Costa Besada MA, et al. Inhibition of the PI3K-AKT-MTORC1 axis reduces the burden of the m.3243A>G mtDNA mutation by promoting mitophagy and improving mitochondrial function. Autophagy. 2024;1\u201316.","DOI":"10.1080\/15548627.2024.2437908"},{"key":"559_CR26","doi-asserted-by":"publisher","unstructured":"F\u00e9lix SS, O\u2019Toole P, Oliveira NAS, Pinho BR, Blacker TS, Fernandes F, et al. Pathological mutation in SMN impairs modulation of GAR1 phase separation linking condensate dysfunction to Spinal Muscular Atrophy. BioRxiv. https:\/\/doi.org\/10.1101\/2025.01.30.635772.","DOI":"10.1101\/2025.01.30.635772"},{"key":"559_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-1-0716-2309-1_25","volume":"2497","author":"K Singh","year":"2022","unstructured":"Singh K, Duchen MR. Analysis of organization and activity of mitochondrial respiratory chain complexes in primary fibroblasts using blue native PAGE. Methods Mol Biol. 2022;2497:339\u201348.","journal-title":"Methods Mol Biol"},{"key":"559_CR28","doi-asserted-by":"crossref","unstructured":"Boutagy NE, Rogers GW, Pyne ES, Ali MM, Hulver MW, Frisard MI. Using isolated mitochondria from minimal quantities of mouse skeletal muscle for high throughput microplate respiratory measurements. J Vis Exp. 2015; e53216.","DOI":"10.3791\/53216"},{"key":"559_CR29","doi-asserted-by":"publisher","first-page":"2200221","DOI":"10.1002\/adbi.202200221","volume":"7","author":"K Neikirk","year":"2023","unstructured":"Neikirk K, Vue Z, Katti P, Rodriguez BI, Omer S, Shao J, et al. Systematic transmission electron microscopy-based identification and 3D reconstruction of cellular degradation machinery. Adv Biol (Weinh). 2023;7:2200221.","journal-title":"Adv Biol (Weinh)"},{"key":"559_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.14348\/molcells.2023.0019","volume":"46","author":"SB Song","year":"2023","unstructured":"Song SB, Shim W, Hwang ES. Lipofuscin granule accumulation requires autophagy activation. Mol Cells. 2023;46:486\u201395.","journal-title":"Mol Cells"},{"key":"559_CR31","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.bbadis.2012.08.012","volume":"1832","author":"M Haltia","year":"2013","unstructured":"Haltia M, Goebel HH. The neuronal ceroid-lipofuscinoses: a historical introduction. Biochim Biophys Acta. 2013;1832:1795\u2013800.","journal-title":"Biochim Biophys Acta"},{"key":"559_CR32","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/nprot.2017.060","volume":"12","author":"N Sun","year":"2017","unstructured":"Sun N, Malide D, Liu J, Rovira II, Combs CA, Finkel T. A fluorescence-based imaging method to measure in vitro and in vivo mitophagy using mt-Keima. Nat Protoc. 2017;12:1576\u201387.","journal-title":"Nat Protoc"},{"key":"559_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32515-6","volume":"13","author":"E Ratto","year":"2022","unstructured":"Ratto E, Chowdhury SR, Siefert NS, Schneider M, Wittmann M, Helm D, et al. Direct control of lysosomal catabolic activity by mTORC1 through regulation of V-ATPase assembly. Nat Commun. 2022;13:4848.","journal-title":"Nat Commun"},{"key":"559_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8007","volume":"6","author":"C Mauvezin","year":"2015","unstructured":"Mauvezin C, Nagy P, Juh\u00e1sz G, Neufeld TP. Autophagosome\u2013lysosome fusion is independent of V-ATPase-mediated acidification. Nat Commun. 2015;6:7007.","journal-title":"Nat Commun"},{"key":"559_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.medpho.2014.12.001","volume":"27","author":"K Suhling","year":"2015","unstructured":"Suhling K, Hirvonen LM, Levitt JA, Chung P-H, Tregidgo C, Le Marois A, et al. Fluorescence lifetime imaging (FLIM): basic concepts and some recent developments. Medical Photonics. 2015;27:3\u201340.","journal-title":"Medical Photonics"},{"key":"559_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nmeth.4074","volume":"14","author":"DS Bindels","year":"2017","unstructured":"Bindels DS, Haarbosch L, Van Weeren L, Postma M, Wiese KE, Mastop M, et al. mScarlet: a bright monomeric red fluorescent protein for cellular imaging. Nat Methods. 2017;14:53\u20136.","journal-title":"Nat Methods"},{"key":"559_CR37","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1021\/acs.jpcc.6b11235","volume":"121","author":"TS Blacker","year":"2017","unstructured":"Blacker TS, Chen W, Avezov E, Marsh RJ, Duchen MR, Kaminski CF, et al. Investigating state restriction in fluorescent protein FRET using time-resolved fluorescence and anisotropy. J Phys Chem C. 2017;121:1507\u201314.","journal-title":"J Phys Chem C"},{"key":"559_CR38","doi-asserted-by":"publisher","first-page":"7883","DOI":"10.1021\/ja312230b","volume":"135","author":"TA Masters","year":"2013","unstructured":"Masters TA, Marsh RJ, Armoogum DA, Nicolaou N, Larijani B, Bain AJ. Restricted state selection in fluorescent protein F\u00f6rster resonance energy transfer. J Am Chem Soc. 2013;135:7883\u201390.","journal-title":"J Am Chem Soc"},{"key":"559_CR39","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/j.molcel.2023.06.004","volume":"83","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zeng W, Han Y, Lee W-R, Liou J, Jiang Y. Lysosomal LAMP proteins regulate lysosomal pH by direct inhibition of the TMEM175 channel. Mol Cell. 2023;83:2524-2539.e7.","journal-title":"Mol Cell"},{"key":"559_CR40","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1038\/emm.2014.128","volume":"47","author":"E-J Bae","year":"2015","unstructured":"Bae E-J, Yang NY, Lee C, Lee H-J, Kim S, Sardi SP, et al. Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and \u03b1-synuclein aggregation. Exp Mol Med. 2015;47:e153\u2013e153.","journal-title":"Exp Mol Med"},{"key":"559_CR41","doi-asserted-by":"publisher","first-page":"eaau6870","DOI":"10.1126\/scitranslmed.aau6870","volume":"11","author":"LF Burbulla","year":"2019","unstructured":"Burbulla LF, Jeon S, Zheng J, Song P, Silverman RB, Krainc D. A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson\u2019s disease. Sci Transl Med. 2019;11:eaau6870.","journal-title":"Sci Transl Med."},{"key":"559_CR42","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/mds.27119","volume":"32","author":"P Garc\u00eda-Sanz","year":"2017","unstructured":"Garc\u00eda-Sanz P, Orgaz L, Bueno-Gil G, Espadas I, Rodr\u00edguez-Traver E, Kulisevsky J, et al. N370S -GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson\u2019s disease. Mov Disord. 2017;32:1409\u201322.","journal-title":"Mov Disord"},{"key":"559_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ceca.2015.11.002","volume":"59","author":"BS Kilpatrick","year":"2016","unstructured":"Kilpatrick BS, Magalhaes J, Beavan MS, McNeill A, Gegg ME, Cleeter MWJ, et al. Endoplasmic reticulum and lysosomal Ca2+ stores are remodelled in GBA1-linked Parkinson disease patient fibroblasts. Cell Calcium. 2016;59:12\u201320.","journal-title":"Cell Calcium"},{"key":"559_CR44","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1093\/hmg\/ddw185","volume":"25","author":"J Magalhaes","year":"2016","unstructured":"Magalhaes J, Gegg ME, Migdalska-Richards A, Doherty MK, Whitfield PD, Schapira AHV. Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease. Hum Mol Genet. 2016;25:3432\u201345.","journal-title":"Hum Mol Genet"},{"key":"559_CR45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.nbd.2018.03.008","volume":"122","author":"C Pitcairn","year":"2019","unstructured":"Pitcairn C, Wani WY, Mazzulli JR. Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson\u2019s disease. Neurobiol of Dis. 2019;122:72\u201382.","journal-title":"Neurobiol of Dis"},{"key":"559_CR46","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41467-023-37454-4","volume":"14","author":"P Baden","year":"2023","unstructured":"Baden P, Perez MJ, Raji H, Bertoli F, Kalb S, Illescas M, et al. Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism. Nat Commun. 2023;14:1930.","journal-title":"Nat Commun"},{"key":"559_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nbd.2015.09.006","volume":"90","author":"ME Gegg","year":"2016","unstructured":"Gegg ME, Schapira AHV. Mitochondrial dysfunction associated with glucocerebrosidase deficiency. Neurobiol of Dis. 2016;90:43\u201350.","journal-title":"Neurobiol of Dis"},{"key":"559_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22113-3","volume":"12","author":"S Kim","year":"2021","unstructured":"Kim S, Wong YC, Gao F, Krainc D. Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson\u2019s disease. Nat Commun. 2021;12:1807.","journal-title":"Nat Commun"},{"key":"559_CR49","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1093\/brain\/awae070","volume":"147","author":"JC Rubilar","year":"2024","unstructured":"Rubilar JC, Outeiro TF, Klein AD. The lysosomal \u03b2-glucocerebrosidase strikes mitochondria: implications for Parkinson\u2019s therapeutics. Brain. 2024;147:2610\u201320.","journal-title":"Brain"},{"key":"559_CR50","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41598-017-18582-6","volume":"8","author":"Y Miyazono","year":"2018","unstructured":"Miyazono Y, Hirashima S, Ishihara N, Kusukawa J, Nakamura K, Ohta K. Uncoupled mitochondria quickly shorten along their long axis to form indented spheroids, instead of rings, in a fission-independent manner. Sci Rep. 2018;8:350.","journal-title":"Sci Rep"},{"key":"559_CR51","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng Y, et al. Mitochondrial dysfunction: mechanisms and advances in therapy. Sig Transduct Target Ther. 2024;9:124.","journal-title":"Sig Transduct Target Ther"},{"key":"559_CR52","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4103\/0028-3886.28112","volume":"54","author":"S Shinde","year":"2006","unstructured":"Shinde S, Pasupathy K. Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from patients with Parkinson\u2032s disease\u202f: preliminary study. Neurol India. 2006;54:390.","journal-title":"Neurol India"},{"key":"559_CR53","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/ana.410370604","volume":"37","author":"RH Haas","year":"1995","unstructured":"Haas RH, Nasirian F, Nakano K, Ward D, Pay M, Hill R, et al. Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson\u2019s disease. Ann Neurol. 1995;37:714\u201322.","journal-title":"Ann Neurol"},{"key":"559_CR54","doi-asserted-by":"publisher","first-page":"fcab215","DOI":"10.1093\/braincomms\/fcab215","volume":"3","author":"JA Tintos-Hern\u00e1ndez","year":"2021","unstructured":"Tintos-Hern\u00e1ndez JA, Santana A, Keller KN, Ortiz-Gonz\u00e1lez XR. Lysosomal dysfunction impairs mitochondrial quality control and is associated with neurodegeneration in TBCK encephaloneuronopathy. Brain Commun. 2021;3:fcab215.","journal-title":"Brain Commun"},{"key":"559_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40035-020-00196-0","volume":"9","author":"Q Song","year":"2020","unstructured":"Song Q, Meng B, Xu H, Mao Z. The emerging roles of vacuolar-type ATPase-dependent lysosomal acidification in neurodegenerative diseases. Transl Neurodegener. 2020;9:17.","journal-title":"Transl Neurodegener"},{"key":"559_CR56","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","volume":"84","author":"JO Lipton","year":"2014","unstructured":"Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014;84:275\u201391.","journal-title":"Neuron"},{"key":"559_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-1-3","volume":"1","author":"SC Yates","year":"2013","unstructured":"Yates SC, Zafar A, Hubbard P, Nagy S, Durant S, Bicknell R, et al. Dysfunction of the mTOR pathway is a risk factor for Alzheimer\u2019s disease. Acta Neuropathol Commun. 2013;1:3.","journal-title":"Acta Neuropathol Commun"},{"key":"559_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1461178","volume":"18","author":"L Chen","year":"2024","unstructured":"Chen L, Saito R, Noda-Narita S, Kassai H, Aiba A. Hyperactive mTORC1 in striatum dysregulates dopamine receptor expression and odor preference behavior. Front Neurosci. 2024;18:1461178.","journal-title":"Front Neurosci"},{"key":"559_CR59","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/npp.2017.247","volume":"43","author":"X Liu","year":"2018","unstructured":"Liu X, Li Y, Yu L, Vickstrom CR, Liu Q. VTA mTOR signaling regulates dopamine dynamics, cocaine-induced synaptic alterations, and reward. Neuropsychopharmacol. 2018;43:1066\u201377.","journal-title":"Neuropsychopharmacol"},{"key":"559_CR60","doi-asserted-by":"crossref","unstructured":"Liu Z, Zhuang W, Cai M, Lv E, Wang Y, Wu Z, et al. Kaemperfol Protects Dopaminergic Neurons by Promoting mTOR-Mediated Autophagy in Parkinson\u2019s Disease Models. Neurochem Res [Internet]. 2022 [cited 2025 Feb 26].","DOI":"10.1007\/s11064-022-03819-2"},{"key":"559_CR61","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.chembiol.2025.02.003","volume":"32","author":"M Ebner","year":"2025","unstructured":"Ebner M, Fr\u00f6hlich F, Haucke V. Mechanisms and functions of lysosomal lipid homeostasis. Cell Chem Biol. 2025;32:392\u2013407.","journal-title":"Cell Chem Biol"},{"key":"559_CR62","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1038\/s42255-022-00706-6","volume":"4","author":"AM Hosios","year":"2022","unstructured":"Hosios AM, Wilkinson ME, McNamara MC, Kalafut KC, Torrence ME, Asara JM, et al. mTORC1 regulates a lysosome-dependent adaptive shift in intracellular lipid species. Nat Metab. 2022;4:1792\u2013811.","journal-title":"Nat Metab"},{"key":"559_CR63","first-page":"194","volume":"109","author":"DJ Sillence","year":"2013","unstructured":"Sillence DJ. Glucosylceramide modulates endolysosomal pH in Gaucher disease. Mol GenetMetab. 2013;109:194\u2013200.","journal-title":"Mol GenetMetab"},{"key":"559_CR64","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1021\/acschemneuro.1c00804","volume":"13","author":"MY Chin","year":"2022","unstructured":"Chin MY, Ang K-H, Davies J, Alquezar C, Garda VG, Rooney B, et al. Phenotypic screening using high-content imaging to identify lysosomal pH modulators in a neuronal cell model. ACS Chem Neurosci. 2022;13:1505\u201316.","journal-title":"ACS Chem Neurosci"},{"key":"559_CR65","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1080\/15548627.2023.2181614","volume":"19","author":"S-H Kim","year":"2023","unstructured":"Kim S-H, Cho Y-S, Kim Y, Park J, Yoo S-M, Gwak J, et al. Endolysosomal impairment by binding of amyloid beta or MAPT\/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease. Autophagy. 2023;19:2318\u201337.","journal-title":"Autophagy"},{"key":"559_CR66","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuroscience.2014.01.001","volume":"263","author":"EE Coffey","year":"2014","unstructured":"Coffey EE, Beckel JM, Laties AM, Mitchell CH. Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer\u2019s disease-linked presenilin 1 A246E mutation can be reversed with cAMP. Neuroscience. 2014;263:111\u201324.","journal-title":"Neuroscience"},{"key":"559_CR67","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/15548627.2015.1136769","volume":"12","author":"M Bourdenx","year":"2016","unstructured":"Bourdenx M, Daniel J, Genin E, Soria FN, Blanchard-Desce M, Bezard E, et al. Nanoparticles restore lysosomal acidification defects: implications for Parkinson and other lysosomal-related diseases. Autophagy. 2016;12:472\u201383.","journal-title":"Autophagy"},{"key":"559_CR68","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1074\/jbc.270.2.815","volume":"270","author":"CJ Sabers","year":"1995","unstructured":"Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G, et al. Isolation of a protein target of the FKBP12-Rapamycin complex in mammalian cells. J Biol Chem. 1995;270:815\u201322.","journal-title":"J Biol Chem"},{"key":"559_CR69","doi-asserted-by":"crossref","unstructured":"Capristo M, Del Dotto V, Tropeano CV, Fiorini C, Caporali L, La Morgia C, et al. Rapamycin rescues mitochondrial dysfunction in cells carrying the m.8344A > G mutation in the mitochondrial tRNALys. Mol Med. 2022; 28:90.","DOI":"10.1186\/s10020-022-00519-z"},{"key":"559_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2024.114889","volume":"463","author":"W Zheng","year":"2024","unstructured":"Zheng W, Li K, Zhong M, Wu K, Zhou L, Huang J, et al. Mitophagy activation by rapamycin enhances mitochondrial function and cognition in 5\u00d7FAD mice. Behav Brain Res. 2024;463:114889.","journal-title":"Behav Brain Res"},{"key":"559_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01373","volume":"9","author":"KG De La Cruz L\u00f3pez","year":"2019","unstructured":"De La Cruz L\u00f3pez KG, Toledo Guzm\u00e1n ME, S\u00e1nchez EO, Garc\u00eda Carranc\u00e1 A. mTORC1 as a regulator of mitochondrial functions and a therapeutic target in cancer. Front Oncol. 2019;9:1373.","journal-title":"Front Oncol"},{"key":"559_CR72","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4161\/15384101.2014.991572","volume":"14","author":"M Morita","year":"2015","unstructured":"Morita M, Gravel S-P, Hulea L, Larsson O, Pollak M, St-Pierre J, et al. mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle. 2015;14:473\u201380.","journal-title":"Cell Cycle"},{"key":"559_CR73","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.arr.2016.04.009","volume":"32","author":"D Carmona-Gutierrez","year":"2016","unstructured":"Carmona-Gutierrez D, Hughes AL, Madeo F, Ruckenstuhl C. The crucial impact of lysosomes in aging and longevity. Ageing Res Rev. 2016;32:2\u201312.","journal-title":"Ageing Res Rev"},{"key":"559_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111443","volume":"25","author":"D Pietrafesa","year":"2024","unstructured":"Pietrafesa D, Casamassa A, Benassi B, Santoro M, Marano M, Consales C, et al. Investigating the impact of the Parkinson\u2019s-associated GBA1 E326K mutation on \u03b2-glucocerebrosidase dimerization and interactome dynamics through an in silico approach. Int J Mol Sci. 2024;25:11443.","journal-title":"Int J Mol Sci"},{"key":"559_CR75","doi-asserted-by":"publisher","first-page":"13813","DOI":"10.1073\/pnas.0605928103","volume":"103","author":"RA Steet","year":"2006","unstructured":"Steet RA, Chung S, Wustman B, Powe A, Do H, Kornfeld SA. The iminosugar isofagomine increases the activity of N370S mutant acid \u03b2-glucosidase in Gaucher fibroblasts by several mechanisms. Proc Natl Acad Sci USA. 2006;103:13813\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"559_CR76","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1074\/jbc.M110.150433","volume":"286","author":"RR Wei","year":"2011","unstructured":"Wei RR, Hughes H, Boucher S, Bird JJ, Guziewicz N, Van Patten SM, et al. X-ray and biochemical analysis of N370S mutant human acid \u03b2-Glucosidase. J Biol Chem. 2011;286:299\u2013308.","journal-title":"J Biol Chem"},{"key":"559_CR77","doi-asserted-by":"publisher","first-page":"10466","DOI":"10.1002\/anie.202002850","volume":"59","author":"C Matassini","year":"2020","unstructured":"Matassini C, Warren J, Wang B, Goti A, Cardona F, Morrone A, et al. Imino\u2010 and azasugar protonation inside human acid \u03b2\u2010glucosidase, the enzyme that is defective in Gaucher disease. Angew Chem Int Ed Engl. 2020;59:10466\u20139.","journal-title":"Angew Chem Int Ed Engl"},{"key":"559_CR78","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/BJ20050325","volume":"390","author":"R Salvioli","year":"2005","unstructured":"Salvioli R, Tatti M, Scarpa S, Moavero SM, Ciaffoni F, Felicetti F, et al. The N370S (Asn370\u2192Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C. Biochem J. 2005;390:95\u2013103.","journal-title":"Biochem J"},{"key":"559_CR79","doi-asserted-by":"publisher","first-page":"42105","DOI":"10.1074\/jbc.M110.172098","volume":"285","author":"MN Offman","year":"2010","unstructured":"Offman MN, Krol M, Silman I, Sussman JL, Futerman AH. Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S. J Biol Chem. 2010;285:42105\u201314.","journal-title":"J Biol Chem"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00559-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-026-00559-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00559-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:03:01Z","timestamp":1782795781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40035-026-00559-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1186\/s40035-026-00559-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7558589\/v1","asserted-by":"object"}]},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Funding statement has been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The sources and ethical approval committees for the iPSCs used in the study are provided in Table S1.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no competing interests in this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}